Found 22 matching trials
Intraocular Pressure Immediately Following Intravitreous Injection of Ranibizumab N/A This study will quantify the intraocular pressure elevation in the immediat...
Show More Location
Retina Support Services, Inc
Learn More & Join Trial
A Phase 3 Safety and Efficacy Study of Fovista® (E10030) Intravitreous Administration in Combination With Lucentis® Compared to Lucentis® Monotherapy PHASE3 The objectives of this study are to evaluate the safety and efficacy of int...
Show More Location
Multiple Locations
Learn More & Join Trial
A Phase 1, Safety, Tolerability and Pharmacokinetic Profile of Intravitreous Injections of E10030 (Anti-PDGF Pegylated Aptamer) in Subjects With Neovascular Age-Related Macular Degeneration PHASE1 The objectives of this study are to evaluate the safety, tolerability, and ...
Show More Learn More & Join Trial
Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab Therapy NA The primary objective:
\*To measure the difference in the number of Ranibi...
Show More Location
Vision Research Foundation
Learn More & Join Trial
Clinical Study to Evaluate PRO-169 for Diabetic Macular Edema PHASE3 Phase III clinical study to evaluate the efficacy, expressed as improvement...
Show More Location
SalaUno Salud, S.A.P.I. de C.V.
Learn More & Join Trial
Ranibizumab and the Risk of Arterial Thromboembolic Events PHASE4 The investigators assume that ranibizumab might be dangerous in patients wi...
Show More Location
De Haar Research Foundation
Learn More & Join Trial
ARC1905 (Anti-C5 Aptamer) Given With Lucentis 0.5 mg In People With Neovascular Age-Related Macular Degeneration PHASE1 The objectives of this study are to evaluate the safety, tolerability, and ...
Show More Learn More & Join Trial
A Study to Establish the Safety and Tolerability of Zimura™ (Anti-C5 Aptamer) in Combination With Anti-VEGF Therapy in Subjects With Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) PHASE2 The objectives of this study are to evaluate the safety and tolerability of...
Show More Location
Multiple Locations
Learn More & Join Trial
Anti-VEGF Intravitreous Injections for Diabetic Macular Edema in Patients Undergoing Cataract Surgery PHASE3 The investigators aim to evaluate how different timing of anti-VEGF intravi...
Show More Location
Changhai Hospital
Learn More & Join Trial
Ranibizumab and Bevacizumab for Diabetic Macular Edema PHASE2 Background:
* Diabetic macular edema is a common eye complication of diabe...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial